In vitro antibacterial activity of thymol and carvacrol and their effects on broiler chickens challenged with 
                   by unknown
RESEARCH Open Access
In vitro antibacterial activity of thymol and
carvacrol and their effects on broiler
chickens challenged with Clostridium
perfringens
Encun Du, Liping Gan, Zhui Li, Weiwei Wang, Dan Liu and Yuming Guo*
Abstract
Background: In the post-antibiotic era, essential oils (EO) are promising alternatives to growth-promoting antibiotics.
The aim of the present study was to investigate the antibacterial activities of an EO product and its components
thymol and carvacrol in vitro, and the efficacy of EO to control Clostridium perfringens challenge in broiler chickens.
Results: The in vitro minimum inhibitory concentration assay showed strong antibacterial activity of the EO product,
thymol, and carvacrol against pathogenic Escherichia coli, C. perfringens, and Salmonella strains, and weak activity
towards beneficial Lactobacillus strains. Besides, an additive effect was observed between thymol and carvacrol. The in
vivo study was carried out with 448 male broiler chicks following a 4 × 2 factorial arrangement to test the effects of EO
supplementation (0, 60, 120, or 240 mg/kg EO in wheat-based diet), pathogen challenge (with or without oral gavage
of C. perfringens from day 14 to day 20) and their interactions. Each treatment consisted of eight replicate pens (seven
birds/pen). The challenge led to macroscopic gut lesions, and resulted in a significant increase in ileal populations of C.
perfringens and Escherichia subgroup (P≤ 0.05) on day 21. Dietary EO supplementation did not influence C. perfringens
numbers, but linearly alleviated intestinal lesions on day 21 and 28 (P = 0.010 and 0.036, respectively), and decreased
Escherichia populations in ileum with increased EO dosages (P = 0.027 and 0.071 for day 21 and 28, respectively). For
caecum, EO quadratically influenced Lactobacillus populations on day 21 (P = 0.002), and linearly decreased the
numbers of total bacteria and Escherichia on day 28 (P = 0.026 and 0.060, respectively). Mean thymol and carvacrol
concentrations in the small intestine were 0.21 and 0.20 μg/g in intestinal digesta (wet weight), respectively, for birds
fed 60 mg/kg EO, and 0.80 and 0.71 μg/g, respectively, for birds fed 240 mg/kg EO.
Conclusions: These results indicated that dietary EO supplementation could affect intestinal microbiota and alleviate
intestinal lesions in broilers, which may contribute in controlling C. perfringens infection in broiler chickens.
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Background
Clostridium perfringens is a Gram-positive, anaerobic,
spore-forming bacterium, which is usually classified into
five toxinotypes (A, B, C, D, and E) according to the pro-
duction of four major toxins, called alpha, beta, epsilon
and iota. Although C. perfringens is a commensal bacter-
ium of the intestine, C. perfringens type A is considered
the main causative agent of necrotic enteritis (NE) in
poultry [1, 2]. Proliferation of pathogenic C. perfringens
and released toxins, especially NetB toxin, result in NE
in poultry [2, 3]. NE is a widespread disease in poultry,
as estimated to cost the international poultry industry
approximately two billion US dollars annually [4]. Im-
paired feed digestion and absorption, reduced growth
rate, and mortality are the major reasons for production
losses associated with NE [2, 5].
The use of in-feed antibiotics has been the main strat-
egy for controlling NE in poultry. However, public con-
cern about the threat of antibiotic-resistant pathogens
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has forced the poultry industry to consider alternatives
to antibiotics for poultry production [5]. Probiotics, pre-
biotics, organic acids, enzymes, and essential oils (EO)
are among the alternatives [5]. Also, because of con-
sumer preference for natural products, the use of EO
has increased appeal [6].
The antibacterial properties of EO have long been rec-
ognized and widely tested in vitro against a wide range
of pathogenic bacteria, including both Gram positive
and Gram negative bacteria [6–8]. Although the antibac-
terial mechanism of EO and their constituents is not
fully understood, studies have shown that constituents
with a phenolic structure, such as eugenol, carvacrol and
thymol have the greatest bactericidal activities, followed
by aldehydes, ketones, alcohols, ethers and hydrocarbons
[9–11]. However, it seems that the efficacy of EO is not
consistent in vivo: both improved and unchanged
growth performance and intestinal microbiota have been
reported in pigs and chickens [6, 8, 12–14]. Actually, it
is difficult to compare the efficacy of EO considering the
fact that EO blends containing various constituents have
been used in vivo in published reports [6, 8, 12–15]. In
addition, little information is available regarding the
relationship between antibacterial activities in vitro and
in vivo. Therefore, the aim of the present study was to
investigate the efficacy of an EO product as well as its
components thymol and carvacrol on pathogenic bac-
teria and benefical Lactobacillus strains, and to investi-
gate the effects of EO on broiler chickens challenged
with C. perfringens. In addition, thymol and carvacrol




Thymol and carvacrol were purchased from Sigma-
Aldrich Corporation (St Louis, MO, USA), with com-
pound purities at ~ 98 %. A commercial EO product was
provided by Novus International Inc. (St Charles, MO,
USA), which contained 25 % thymol and 25 % carvacrol
as active components, 37 % silicon dioxide as a caking
inhibitor, and 13 % glycerides as stabilizing agents.
Preparation of cultures
Thymol, carvacrol and the commercial EO product were
individually tested against a panel of undesirable bacteria
and beneficial Lactobacillus strains. The undesirable bac-
teria included two chicken Escherichia coli field strains
CVCC1553 and CVCC1490 (serotype O78), chicken C.
perfringens field strains (CVCC2027 and CVCC2030),
Salmonella enterica serovar Typhimurium (CVCC541),
Salmonella enterica serovar Enteritidis (CVCC2184) and
Salmonella enterica serovar Pullorum (C79-13), which
were obtained from China Veterinary Culture Collection
Center (Beijing, China). Another S. Enteritidis field
strain (ATCC13076) was obtained from American Type
Culture Collection (Manassas, VA, USA). In addition,
three strains of Lactobacillus were tested. L. acidophilus
(GIM1.730) was obtained from Guangdong Microbiol-
ogy Culture Center (Guangdong, China), and L. reuteri
and L. salivarius were isolated from the gastrointestinal
content of healthy broiler chickens by our laboratory
staff.
Overnight cultures of E. coli and Salmonella were pre-
pared freshly by cultivation from frozen stock at 37 °C in
Luria-Bertani broth with continuous shaking. Cultures
of C. perfingens were prepared anaerobically at 37 °C
overnight in cooked meat medium and Man-Rogosa-
Sharpe (MRS) broth used for growing of Lactobacillus at
37 °C without shaking.
Minimum inhibitory concentration and minimal
bactericidal concentration assay
The minimum inhibitory concentration (MIC) was de-
termined via a conventional broth dilution method, as
described by Ivanovic et al. with some modifications
[16]. Briefly, the commercial EO product, thymol, and
carvacrol were initially dissolved as 300 mg/mL stock
solution in dimethylsulfoxide (DMSO) and diluted to
6 mg/mL in Mueller-Hinton broth with vigorous shak-
ing. Then, two-fold serial dilutions of thymol and carva-
crol were prepared, producing concentrations at 6000,
3000, 1500, 750, 375, 187.5, 93.75 and 46.875 μg/mL.
For the detection of Lactobacillus, MRS broth was used
for dilution. In order to avoid the antibacterial effects of
DMSO itself, the final DMSO concentrations never
exceeded 2 % (by volume). Then, each diluted broth was
inoculated with fresh microbial suspension (final con-
centration: 1 ~ 5 × 105 colony-forming units (cfu)/mL).
E. coli and Salmonella were incubated at 37 °C with con-
tinuous shaking overnight. C. perfringens and Lactobacil-
lus were incubated anaerobically at 37 °C for 24 and
16 h, respectively, without shaking. A positive growth
control containing 2 % DMSO without EO or compo-
nents, and a negative control containing no bacteria
were included in each experiment. After incubation, the
optical density (OD) of suspension was measured using
a spectrophotometer at 595 nm. In addition, 50 μL from
each broth dilution was inoculated for enumeration in
duplicate onto nutrient agar for E. coli and Salmonella,
sulfite-polymyxin-sulfadiazine agar for C. perfringens,
and MRS agar for Lactobacillus, all by the spread plate
method. MIC was defined as the lowest concentration of
EO or components that showed no increase in OD follow-
ing incubation. The minimal bactericidal concentration
(MBC) was defined as the lowest concentration of EO or
components with which no viable bacteria were detected.
All assays were performed in triplicate.
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Combination assay
A combination assay between thymol and carvacrol
was performed by the checkerboard method, as previ-
ously described [17]. Two-fold serial dilutions of one
component were tested in the presence of serial con-
centrations of the other component (which did not
inhibit bacterial growth alone). The fractional inhibi-
tory concentration (FIC) was calculated as follows:
FIC of component A =MIC of component A in com-
bination divided by the MIC of component A alone,
FIC of component B =MIC of component B in com-
bination divided by the MIC of component B alone,
and FIC index (FICI) = FIC of component A + FIC of
component B. An FICI < 0.5 was considered to dem-
onstrate synergy. When an FICI fell between 0.5 and
1.0, it was defined as an additive effect and, between
1.0 and 4.0, it was classified as no interaction. Finally,
an FICI > 4.0 indicated antagonism between the com-
ponents in a combination.
In vivo study
Birds, diets, and experimental design
All experimental procedures were approved by the
China Agricultural University Animal Care and Use
Committee. A total of 448 one-day-old male broiler
chicks (Cobb 500) were used for a 28-day experiment.
Chicks were assigned to eight treatments, following a
4 × 2 factorial arrangement in a randomized complete
block design to evaluate dietary EO supplementation
(0, 60, 120, or 240 mg/kg EO in wheat-based diet),
pathogen challenge (with or without oral gavage of C.
perfringens from day 14 to 21) and their interactions.
Each treatment consisted of eight replicate pens
(seven birds/pen). The EO used in this trial was the
commercial product mentioned above, which con-
tained 25 % thymol and 25 % carvacrol as active
components. Chickens were fed starter (day 0–21)
and finisher (day 21–28) diets in the form of mash
and had access to feed and water ad libitum. Prolifer-
ation of C. perfringens was promoted by formulating
antibiotic-free and coccidiostat-free wheat-based diets.
All nutrients were formulated to meet or exceed the
feeding standard of China (NY/T 2004) for broilers
[18] (Table 1).
Clostridium perfringens challenge and sampling
C. perfringens challenge was conducted as originally
developed by Dahiya et al. [19]. The particular organ-
ism, CVCC2027, was a type A field strain, isolated
from a clinical case of NE in chickens, which did not
carry the NetB gene, as determined by polymerase
chain reaction (PCR). Briefly, the organism was cul-
tured anaerobically on tryptose-sulphite-cycloserine
agar base at 37 °C for 18 h, and then aseptically
inoculated into cooked meat medium and incubated
anaerobically at 37 °C overnight. All birds in chal-
lenged groups were orally gavaged in the crop once
per day with 1.0 mL of actively growing C. perfringens
culture from day 14 to 20 (1.0 × 108 cfu/mL). On
day 21 and 28, one bird per replicate was randomly
selected and killed by intracardial administration of
sodium pentobarbital (30 mg/kg body weight) and
jugular exsanguination prior to sample collection.
Intestinal lesion score
The small intestine from each bird was opened and
scored blindly on a scale from zero to four as de-
scribed by Dahiya et al. [19]: 0 = normal intestinal ap-
pearance with no lesion, 0.5 = severely congested
serosa and mesentery engorged with blood, 1 = thin
walled and friable intestines with small red petechiae
(>5), 2 = focal necrotic lesions, 3 = patches of necrosis
(1 to 2 cm-long), and 4 = diffused necrosis typical of
field cases.
Bacteriological examination
On day 21 and day 28, digesta for bacteriological
examination were collected aseptically from ileum
(from ileum midpoint to 2 cm proximal to ileocecal
junction) and caecum, and stored at −80 °C. Bacterial
populations were detected by the method of absolute
quantitative real-time PCR (RT-PCR), as described by
Wise and Siragusa, with some modifications [20].
Genomic DNA was isolated from 200 mg of digesta
from ileum and caecum using a commercial kit
(QIAamp DNA Stool Mini Kit, Qiagen Inc., Valencia,
CA, USA). Extracted DNA was stored at −20 °C until
analysis.
Standard curves for RT-PCR were prepared using
DNA extracted from pure cultures to produce a high
concentration of the target DNA by normal PCR ampli-
fication. Primer sequences were used in previous studies,
which were designed on the basis of 16s rDNA se-
quences [21–23]. Target groups, primer sequences,
amplicon sizes, and references are shown in Table 2.
The targeted Escherichia subgroup contained genera of
E. coli, Hafnia alvei and Shigella [22]. E. coli competent
cells DH5α (Takara Bio Inc., Japan) were used to create
plasmid standards. Firstly, PCR products were purified
using a PCR purification kit (Biomed Gene Technolo-
gies, Beijing, China), and then cloned into pCR®2.1 using
a TA cloning kit (Invitrogen Corporation, Carlsbad, CA,
USA), following the manufacturer’s protocol. Purified
insert-containing plasmids were quantified using a
Nanodrop ND-1000 spectrophotometer (Thermo Fisher
Scientific Inc., Waltham, MA, USA), and the number of
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target gene copies was calculated by the following for-
mula according to Lee et al. [24]:
DNA copyð Þ ¼ 6:02 10
23 copy=molð Þ  DNA amount gð Þ
DNA length dpð Þ  660 g=mol=dpð Þ
ð1Þ
Ten-fold serial dilutions of plasmid DNA were in-
cluded on each 96-well plate to produce a standard
curve. Genomic DNA from ileal samples and cecal
samples was used as templates for absolute quantita-
tive RT-PCR with a 7500 fluorescence detection system
(Applied Biosystems, Foster City, CA, USA) according
to optimized PCR protocols (SYBR-Premix Ex Taq,
Takara Bio Inc., Japan). RT-PCR primers were the same
as for normal PCR amplification primers (Table 2).
Normal distributions were achieved by showing the re-
sults in terms of log10 gene copies/g intestinal digesta.
Table 1 Diet composition and nutrient levels
Item (%, unless otherwise indicated) Starter diets (day 0–21) Grower diets (day 22–28)
Ingredient
Wheat 62.75 68.5
Soybean meal 29.61 23.72
Soybean oil 3.40 4.00
Dicalcium phosphate 1.91 1.63
Limestone 1.04 0.96
Sodium chloride 0.35 0.35
Choline chloride (50 %) 0.25 0.25
L-Lysine (99 %) 0.25 0.24
DL-Methionine (98 %) 0.19 0.11
Antioxidants 0.03 0.03
Trace mineral premix a 0.20 0.20
Vitamin premix b 0.02 0.02
Calculated nutrient levels
Metabolizable energy (Mcal/kg) 2.90 2.98
Protein 21.00 19.00
Calcium 1.00 0.90
Available phosphorus 0.45 0.40
Lysine 1.15 1.00
Methionine 0.50 0.40
a The trace mineral premix provided the following (per kilogram of diet): manganese, 100 mg; zinc, 75 mg; iron, 80 mg; copper, 8 mg; selenium, 0.25 mg;
iodine, 0.35 mg
b The vitamin premix provided the following (per kilogram of diet): vitamin A, 18750 IU; vitamin D3, 3750 IU; vitamin E, 28 IU; vitamin K3, 3.975 mg; thiamine
mononitrate, 3 mg; riboflavin, 9 mg; vitamin B12, 0.0375 mg; d-biotin, 0.150 mg; folic acid, 1.875 mg; d-calcium pantothenate, 18 mg; nicotinic acid, 75 mg
Table 2 16s rDNA real-time PCR primers used to quantify intestinal bacteria
Target Primer sequence (5′–3′) a Amplicon size (bp) Reference
Total bacteria F:ACTCCTACGGGAGGCAGCAGT 200 [19]
R:GTATTACCGCGGCTGCTGGCAC
Lactobacillus subgroup F:AGCAGTAGGGAATCTTCCA 341 [19]
R:CACCGCTACACATGGAG
Escherichia subgroup b F:GTTAATACCTTTGCTCATTGA 340 [20]
R:ACCAGGGTATCTAATCCTGT
Clostridium perfringens F:AAAGATGGCATCATCATTCAAC 279 [21]
R:TACCGTCATTATCTTCCCCAAA
a F means forward, R means reverse
b The targeted Escherichia subgroup contained genera of E. coli, Hafnia alvei and Shigella
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Chemical analysis for thymol and carvacrol
On day 21, fresh digesta collected from small intestine
(5 cm proximal to Meckel’s diverticulum) were acidified
to pH < 2 with 2 % of 6 mol H2SO4 per litre to stop
fermentation and stored at −20 °C pending analysis for
thymol and carvacrol. Quantification of thymol and
carvacrol in intestinal digesta was performed, as de-
scribed by Michiels et al. with some modifications
[25]. Briefly, 2.0 g of digesta from each bird were used
for extraction, and 4 mL ethyl ethanoate was added as
extraction solvent. All extractions were performed in
duplicate. 2.5 mg of 2-isopropylphenol/mL of ethyl
ethanoate was used as the internal standard. Ethyl eth-
anoate extracts were combined and reduced to dryness
with nitrogen at room temperature. Then, the residue
redissolved in ethyl ethanoate was used for gas chro-
matographic analysis.
Statistical analysis
Results are given as mean values and pooled standard er-
rors. Data were analyzed using the general linear model
procedure of SAS software (SAS Institute Inc., Cary,
NC, USA). The main effects of C. perfringens challenge,
EO supplementation, and their interactive effects were
analyzed. Duncan’s multiple-range tests were used to
separate means when interactions were significant.
When interactions were not significant, polynomial con-
trasts were conducted to determine linear and quadratic
responses of the main-effect means (averaged between
challenged and unchallenged groups) to dietary EO dos-
ages. Statistical significance was considered at P ≤ 0.05,
and 0.05 < P < 0.10 was considered a trend towards
significance.
Results
In vitro antibacterial activity of EO and components
The antibacterial activities of EO and components (thy-
mol and carvacrol) against selected pathogenic bacteria
and beneficial Lactobacillus strains were expressed as
MICs and MBCs (Table 3). Among the eight pathogenic
bacteria, E. coli was more sensitive to thymol (MIC and
MBC, 187.5 and 375 μg/mL, respectively). In contrast, S.
Enteritidis was more sensitive to carvacrol (MIC and
MBC, 187.5 and 750 μg/mL, respectively). However, the
greatest MIC and MBC were obtained for thymol in the
presence of S. Enteritidis (750 and 1500 μg/mL, respect-
ively). Thymol and carvacrol exhibited the same antibac-
terial activity against C. perfringens, S. Typhimurium and
S. Pullorum (MIC and MBC, 375 and 750 μg/mL, re-
spectively). Moreover, the tested EO product showed
identical antibacterial activity against all eight patho-
genic bacteria (MIC and MBC, 750 and 1500 μg/mL,
respectively). In addition, antibacterial activity of thy-
mol and carvacrol was noticed against L. acidophilus,
L. reuteri and L. salivarius at concentrations higher
than for pathogenic bacteria (MIC and MBC, 1500
and 3000 μg/mL, respectively). The EO was also ob-
served to inhibit Lactobacillus growth (MIC and
MBC, both 3000 μg/mL). In addition, the FICI to-
wards all tested bacteria fell between 0.5 and 1.0, dem-
onstrating an additive antibacterial effect between
thymol and carvacrol.
Intestinal lesion score
No intestinal lesions were observed in unchallenged
birds. In challenged groups, intestinal lesion scores were
reduced linearly with increased dietary EO dosages on
day 21 and day 28 (P = 0.010 and 0.036, respectively,
Fig. 1). Compared with birds fed basal diet, lesion sever-
ity in broilers fed 240 mg/kg EO was reduced signifi-
cantly on day 21 (P ≤ 0.05), and lesion severity of
broilers fed 120 and 240 mg/kg EO was reduced signifi-
cantly on day 28 (P ≤ 0.05).
Quantitation of ileal and cecal microbiota
C. perfringens challenge led to significant increases in
ileal populations of Escherichia subgroup (P < 0.001) and
C. perfringens (P = 0.03) on day 1 post-challenge (Table 4).
Table 3 Antibacterial activity of essential oils and components towards selected bacteria
Bacteria MIC (μg/mL) MBC (μg/mL) FICI
EO Thymol Carvacrol EO Thymol Carvacrol
Escherichia coli 750 187.5 375 1500 375 750 0.5
Clostridium perfringens 750 375 375 1500 750 750 0.5
Salmonella Typhimurium 750 375 375 1500 750 750 0.5
Salmonella Enteritidis 750 750 187.5 1500 1500 750 1.0
Salmonella Pullorum 750 375 375 1500 750 750 0.5
Lactobacillus acidophilus 3000 1500 1500 3000 3000 3000 1.0
Lactobacillus reuteri 3000 1500 1500 3000 3000 3000 1.0
Lactobacillus salivarius 3000 1500 1500 3000 3000 3000 1.0
MIC, the minimum inhibitory concentration; MBC, the minimal bactericidal concentration; EO, essential oil contained 25 % thymol and 25 % carvacrol as active
components; FICI, fractional inhibitory concentration index
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However, on day 7 post-challenge, ileal microbiota of chal-
lenged birds were restored to the level of unchallenged
birds (P > 0.10, Table 5). Dietary supplementation of EO
did not influence C. perfringens numbers, but linearly de-
creased Escherichia numbers in ileum on day 21 and 28
(P = 0.027 and 0.071, respectively) regardless of challenge
(Tables 4 and 5). For cecal microbiota, the population
of C. perfringens was increased on day 1 post-challenge
(P < 0.001, Table 6), and showed a tendency to increase
on day 7 post-challenge (P = 0.078, Table 7). Dietary EO
supplementation influenced cecal Lactobacillus numbers
quadratically (P = 0.002) on day 21 (Table 6). Compared
with birds fed basal diet, higher Lactobacillus populations
were observed in birds fed 60 mg/kg and 120 mg/kg
EO on day 21 in both unchallenged and challenged
groups (Table 6). In contrast, the populations of
total bacteria and Escherichia in caecum decreased
linearly with increased EO dosages on day 28 (P =
0.026 and 0.060, respectively, Table 7). No interac-
tions were observed for ileal and cecal microbiota
between C. perfringens challenge and EO supplemen-
tation (P > 0.10, Table 4, 5, 6 and 7).
Fig. 1 Effects of essential oils on intestinal lesion score of Clostridium perfringens challenged broiler chickens. Values are means of eight replicates
per treatment and pooled standard error of the mean. Bars not sharing a common letter differ significantly (P ≤ 0.05). EO, essential oils; P (linear),
polynomial contrasts were conducted to determine the linear response of lesion score to dietary EO dosages
Table 4 Effect of essential oils on ileal bacterial populations of broilers on day 21
Item a Total bacteria Lactobacillus Escherichia C. perfringens
Treatment
Basal diet, unchallenged 9.00 7.89 8.00 2.27
60 mg/kg EO, unchallenged 9.28 7.98 7.60 2.35
120 mg/kg EO, unchallenged 9.35 8.30 7.55 2.34
240 mg/kg EO, unchallenged 9.22 8.14 7.15 2.34
Basal diet, challenged 9.41 8.11 8.72 2.50
60 mg/kg EO, challenged 9.48 8.38 8.99 2.39
120 mg/kg EO, challenged 9.44 8.39 8.26 2.43
240 mg/kg EO, challenged 9.29 8.27 8.03 2.57
SEM 0.068 0.073 0.137 0.033
P-value
Challenge 0.185 0.169 <0.001 0.030
EO 0.735 0.438 0.095 0.805
Challenge × EO 0.828 0.888 0.713 0.655
Linear b 0.945 0.366 0.027 0.553
Quadratic b 0.261 0.172 0.853 0.707
a Values are means of eight replicates per treatment, and expressed as log10 (copy/g digesta). EO, essential oils; unchallenged, birds without challenge of C.
perfringens; challenged, birds challenged with C. perfringens from day 14 to 20; SEM, pooled standard error of the mean; Challenge × EO, interaction between C.
perfringens challenge and EO supplementation
b When interaction between C. perfringens challenge and EO supplementation was not significant, linear and quadratic polynomial contrasts were performed on
the main-effect means to EO dosages
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Table 5 Effect of essential oils on ileal bacterial populations of broilers on day 28
Item a Total bacteria Lactobacillus Escherichia C. perfringens
Treatment
Basal diet, unchallenged 9.13 7.70 6.09 3.00
60 mg/kg EO, unchallenged 9.08 7.76 6.27 2.79
120 mg/kg EO, unchallenged 8.85 7.71 5.90 2.94
240 mg/kg EO, unchallenged 9.13 7.76 5.91 2.84
Basal diet, challenged 9.26 7.99 6.13 2.96
60 mg/kg EO, challenged 9.33 8.18 6.56 3.04
120 mg/kg EO, challenged 9.08 7.98 5.76 2.95
240 mg/kg EO, challenged 8.91 7.80 5.60 2.95
SEM 0.058 0.081 0.098 0.051
P-value
Challenge 0.421 0.135 0.887 0.462
EO 0.365 0.877 0.092 0.953
Challenge × EO 0.469 0.882 0.742 0.789
Linear b 0.215 0.662 0.071 0.619
Quadratic b 0.502 0.708 0.780 0.931
a Values are means of eight replicates per treatment, and expressed as log10 (copy/g digesta). EO, essential oils; unchallenged, birds without challenge of C.
perfringens; challenged, birds challenged with C. perfringens from day 14 to 20; SEM, pooled standard error of the mean; Challenge × EO, interaction between C.
perfringens challenge and EO supplementation
b When interaction between C. perfringens challenge and EO supplementation was not significant, linear and quadratic polynomial contrasts were performed on
the main-effect means to EO dosages
Table 6 Effect of essential oils on cecal bacterial populations of broilers on day 21
Item a Total bacteria Lactobacillus Escherichia C. perfringens
Treatment
Basal diet, unchallenged 11.16 8.52 9.77 3.05
60 mg/kg EO, unchallenged 11.50 8.86 9.53 2.38
120 mg/kg EO, unchallenged 11.41 9.16 9.51 2.83
240 mg/kg EO, unchallenged 11.42 8.69 9.41 2.41
Basal diet, challenged 11.28 8.60 9.28 3.68
60 mg/kg EO, challenged 11.43 9.02 9.42 3.63
120 mg/kg EO, challenged 11.40 9.06 9.46 3.30
240 mg/kg EO, challenged 11.37 8.70 9.34 3.39
SEM 0.041 0.068 0.085 0.110
P-value
Challenge 0.973 0.785 0.316 <0.001
EO 0.190 0.022 0.952 0.327
Challenge × EO 0.842 0.916 0.783 0.466
Linear b 0.299 0.673 0.566 0.270
Quadratic b 0.129 0.002 0.927 0.606
a Values are means of eight replicates per treatment, and expressed as log10 (copy/g digesta). EO, essential oils; unchallenged, birds without challenge of C.
perfringens; challenged, birds challenged with C. perfringens from day 14 to 20; SEM, pooled standard error of the mean; Challenge × EO, interaction between C.
perfringens challenge and EO supplementation
b When interaction between C. perfringens challenge and EO supplementation was not significant, linear and quadratic polynomial contrasts were performed on
the main-effect means to EO dosages
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Thymol and carvacrol concentrations in intestinal digesta
Thymol and carvacrol concentrations in intestinal
digesta linearly increased with increased dietary EO dos-
ages (P < 0.001, Table 8). For birds fed 240 mg/kg EO,
thymol and carvacrol accounted for 60 mg/kg, as each
comprised 25 % of the EO product. Their average con-
centrations in intestinal digesta were 0.80 and 0.71 μg/g
(based on digesta wet weight) respectively, which were
significantly higher than concentrations assayed in birds
fed 60 and 120 mg/kg EO (P ≤ 0.05).
Discussion
EO and their purified constituents are promising alter-
natives to growth-promoting antibiotics, and they are
generally recognized as safe [6]. Among thousands of
EO constituents, thymol and its isomer carvacrol are the
main components of commonly used oregano and
thyme oil [26]. In the present study, strong antibacterial
effects of an EO product and its components thymol
and carvacrol were observed in vitro against a panel of
pathogenic bacteria, including E. coli, Salmonella, and C.
perfringens. In broiler chickens challenged with C. per-
fringens, dietary supplementation of thymol and
carvacrol-bearing EO did not influence C. perfringens
numbers. However, EO did alter Escherichia and Lacto-
bacillu populations, and alleviated intestinal lesions in a
linear dose-related manner. In addition, thymol and car-
vacrol concentrations in intestinal digesta were assayed
in this study.
Many studies have tested the antibacterial activity of
EO, or their constituents, against foodborne pathogens
[11, 16, 26–30]. According to Pei et al., MICs of thymol
and carvacrol against E. coli were both 400 μg/mL [26].
And Ivanovic et al. have reported that E. coli and S.
Enteritidis are inhibited by thymol at concentrations be-
tween 160 and 320 μg/mL [16]. Also, C. perfringens was
inhibited effectively by thymol and carvacrol (MICs of
240 and 300 μg/mL, respectively) [29, 31]. In the present
Table 7 Effect of essential oils on cecal bacterial populations of broilers on day 28
Item a Total bacteria Lactobacillus Escherichia C. perfringens
Treatment
Basal diet, unchallenged 11.18 9.14 8.83 2.68
60 mg/kg EO, unchallenged 11.19 9.10 8.66 2.54
120 mg/kg EO, unchallenged 11.31 9.16 8.80 2.55
240 mg/kg EO, unchallenged 11.00 8.99 8.55 2.42
Basal diet, challenged 11.18 9.22 9.24 2.79
60 mg/kg EO, challenged 11.24 9.30 9.01 3.24
120 mg/kg EO, challenged 10.89 9.19 8.77 2.78
240 mg/kg EO, challenged 10.81 9.02 8.42 2.47
SEM 0.046 0.056 0.092 0.077
P-value
Challenge 0.126 0.473 0.428 0.078
EO 0.076 0.624 0.269 0.205
Challenge × EO 0.220 0.951 0.685 0.406
Linear b 0.026 0.255 0.060 0.112
Quadratic b 0.399 0.509 0.928 0.437
a Values are means of eight replicates per treatment, and expressed as log10 (copy/g digesta). EO, essential oils; unchallenged, birds without challenge of C.
perfringens; challenged, birds challenged with C. perfringens from day 14 to 20; SEM, pooled standard error of the mean; Challenge × EO, interaction between C.
perfringens challenge and EO supplementation
b When interaction between C. perfringens challenge and EO supplementation was not significant, linear and quadratic polynomial contrasts were performed on
the main-effect means to EO dosages
Table 8 Analytical concentrations of thymol and carvacrol in intestinal digesta
Item a Dietary EO concentration (mg/kg) SEM P-value Linear b Quadratic b
0 60 120 240
Thymol (μg/g digesta) ND 0.21B 0.46B 0.80A 0.076 <0.001 <0.001 0.586
Carvacrol (μg/g digesta) ND 0.20B 0.29B 0.71A 0.076 <0.001 <0.001 0.677
a Values are means of eight replicates per treatment. Means within the same row not sharing a common uppercase superscript letter differ significantly (P ≤ 0.05).
EO, essential oil contained 25 % thymol and 25 % carvacrol as active components; SEM, pooled standard error of the mean; ND, not detected
b Linear and quadratic responses of intestinal thymol or carvacrol concentrations to dietary EO dosages
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study, strong antibacterial effects of thymol and carva-
crol were observed against selected pathogenic bacteria,
and similar MICs of thymol and carvacrol were obtained
to previous reports. In addition, the E. coli strains we
used were more sensitive to thymol, while the S. Enteri-
tidis strains we used were more sensitive to carvacrol,
compared with other pathogens. Besides, the antibacter-
ial activity of the EO product was comparable to thymol
and carvacrol according to the present work, taking into
account that the EO product contained 25 % each of
thymol and carvacrol as active components.
However, limited information is available regarding EO
effects on beneficial probiotic bacteria, such as Lactoba-
cillus. Only slight or no inhibition against Lactobacillus
has been reported for carvacrol at 300 μg/mL, according
to Si et al. [31]. In the present study, higher concentra-
tions of thymol and carvacrol (up to 6000 μg/mL) were
used to explore their bactericidal activities. The growth
of L. acidophilus, L. reuteri and L. salivarius was ob-
served to be inhibited by thymol and carvacrol at an
MIC of 1500 μg/mL, and be killed at twice the concen-
tration, the MBC. Also, the EO product was able to kill
the tested Lactobacillus strains at 3000 μg/mL. Ouwe-
hand et al. have pointed out that L. fermentum and L.
reuteri growth is inhibited by thymol itself as well as by
EO (oregano, rosemary and thyme oils, whose main con-
stitutes were thymol and/or carvacrol) at 500 μg/mL
[32]. However, no antibacterial effects against L. plan-
tarum were found for carvacrol even at 3000 μg/mL in
Ben Arfa et al.’s study [9]. The contrary results observed
here might be explained by differences in the examined
Lactobacillus field strains. In addition, the final concen-
trations of microbial suspensions in the present study
were 1-5 × 105 cfu/mL for the MIC assays, but a differ-
ent range of 106–107 cfu/mL was employed in Ben Arfa
et al.’s study [9]. Nevertheless, the present results
showed that Lactobacillus appeared more resistant to
EO and its constitutes than pathogenic bacteria did,
which might indicate that intestinal microbiota in ani-
mals might be favored under certain concentrations of
EO and its constituents.
According to in vitro experiments, additive antibacter-
ial effects between thymol and carvacrol were observed
towards all tested bacteria, as the FICI was between 0.5
and 1.0, and FICI was applied to define the nature of
interaction. However, FICI values used for the definition
of interaction differed between publications, which
makes comparison of studies difficult [33]. The defin-
ition we adopted in the present study appears to be
more acceptable in literature [33]. Based on the defin-
ition in the present study, an additive effect (FICI of
0.75) between thymol and carvacrol against E. coli also
has been observed in previous studies [26, 27]. Similarly,
Lambert et al. have reported that thymol and carvacrol
in combination show additive effects against Pseudo-
monas aeruginosa and Staphylococcus aureus using half-
fold dilutions within a Bioscreen plate [34]. In addition,
the additive effects observed here were in agreement
with the antibacterial activity of the EO product, whose
MIC and MBC were comparable to its active compo-
nents thymol and carvacrol. This would be expected as
thymol and carvacrol are isomers with similar chemical
structures and likely to have similar mechanisms of anti-
microbial activity [35].
In in vivo trial, wheat-based diets were used to favor
C. perfringens colonization. However, the challenge did
not result in overtly clinical signs of NE or NE-related
mortality in the present trial. The deficiency of NetB
gene in the C. perfringens strain used here might par-
tially explain the loss of characteristic NE, as NetB has
been observed to play a major role in NE [3, 36]. Despite
this, C. perfringens challenge damaged intestinal mucosa,
as observed by macroscopic lesions, which was similar
to previous studies using the same challenge model to
create sub-clinical NE [37, 38]. And dietary EO supple-
mentation alleviated intestinal lesions linearly on day 21
and 28. This was in agreement with previous studies,
which have reported that thymol and carvacrol-bearing
EO alleviates C. perfringens-induced gut lesions [29, 39].
The abundance of total bacteria, Lactobacillus, Escher-
ichia, and C. perfringens in the gut was estimated using
absolute RT-PCR to evaluate group-specific 16s rDNA
in extracted community DNA of intestinal digesta. Ac-
cording to Dahiya et al., C. perfringens numbers can
reach 107–109 cfu/g digesta in typical clinical NE [5],
but C. perfringens numbers were lower than 104 cfu/g
digesta in the present study. Even though, microbial
populations dramatically changed when birds were in-
fected with C. perfringens, with C. perfringens popula-
tions significantly increased in both ileum and caecum
on day 1 post-challenge. These changes were also ac-
companied by a significant Escherichia increase in ileum.
Many populations of bacteria have been reported to co-
exist with NE and one of the largest populations is E.
coli [40]. This was consistent with the results obtained
in the current study as well as other work performed by
Liu et al. [38].
The results of the present work indicated that dietary
supplementation of EO linearly decreased ileal Escheri-
chia counts on day 21 and 28, and linearly decreased the
number of total bacteria in caecum on day 28. In
addition, Lactobacillus counts were quadratically af-
fected by dietary EO addition in caecum on day 21.
Similarly, Jamroz et al. have reported that the combin-
ation of carvacrol, cinnamaldehyde and capsaicin de-
creases E. coli populations and increase Lactobacillus
numbers in broilers fed a wheat-based diet [14]. Also,
EO extracted from thyme and anise have been reported
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to decrease C. perfringens and E. coli counts in both
small and large intestines, accompanied by decreased in-
testinal lesion score [41]. Changes in intestinal microbiota
might be related to alleviation of intestinal lesions with
EO supplementation. Interestingly, no inhibition of C. per-
fringens was observed for thymol and carvacrol in the
present study. This was inconsistent with results obtained
by Jamroz et al. and Cho et al. regarding the effects of EO
on C. perfringens [14, 41]. Notably, in Abildgaard et al.’s
study, C. perfringens numbers were not influenced by diet-
ary supplementation of an EO product (containing
thymol, eugenol, curcumin, and piperin) [42]. In fact, dif-
ferent from the well-known antibacterial activities of EO
in vitro, their in vivo effects on intestinal bacteria are ra-
ther limited with variable results. For example, no alter-
ation in intestinal microbiota was observed in broilers fed
an EO-supplemented diet according to Cross et al. and
Hong et al. [12, 13]. As mentioned above, EO blends con-
taining various constituents have been used in vivo in
published reports, making it difficult to compare their effi-
cacy [6, 8, 12–15].
The antibacterial efficacy of EO is related to the con-
centrations of active components. However, studies have
shown that most EO are absorbed quickly after oral ad-
ministration. According to Kohlert et al., peak plasma
thymol concentration was reached after 2 h in humans
[43]. In piglets, plasma thymol and carvacrol concentra-
tions peaked at 1.39 and 1.35 h, respectively, and thymol
and carvacrol were almost completely absorbed in stom-
ach and proximal small intestine [25]. To exert antibac-
terial activity in vivo, it has been suggested that delivery
protection is needed to aid EO in reaching target sites
within the gut [44, 45]. In the present study, the EO
product was stabilized with glycerides. Since little infor-
mation is available regarding the release of active EO
components in broiler intestine, thymol and carvacrol
concentrations in intestinal digesta were measured in
the present study. It was observed that intestinal thymol
and carvacrol concentrations increased linearly with in-
creased dietary EO dosages. The highest concentrations
observed for thymol and carvacrol were 0.80 and
0.71 μg/g, respectively, in broilers fed 240 mg/kg EO.
This was in accordance with the linear inhibition effects
of EO on Escherichia in broilers. Similarly, Michiels et
al. have investigated thymol and carvacrol concentra-
tions in piglet gastrointestinal digesta [46]. They ob-
served 5 μg/g carvacrol in the proximal small intestine
of piglets fed 2 g/kg carvacrol diet, and 13 ~ 24 μg/g thy-
mol in piglets fed 2 g/kg thymol diet [46]. Although the
EO used here was coated with glycerides, the analyzed
luminal concentrations of thymol and carvacrol were
quite low (much lower than their MICs in vitro), which
may partially explain the unchanged C. perfringens pop-
ulations in vivo. To our knowledge, this is the first time
that in vitro antibacterial activities and luminal availabil-
ity of active EO constituents in chicken were investi-
gated, providing a link between EO activities in vitro and
their effects in vivo. According to our finding, more effi-
cient protection and release techniques are necessary to
improve luminal availability of EO constituents.
Interestingly, some reports have shown that sub-lethal
EO concentrations have important effects on bacterial
activity [47, 48]. According to Inamuco et al., at concen-
trations where growth of Salmonella was not inhibited,
carvacrol completely inhibited Salmonella motility, and
reduced its invasion of porcine intestinal epithelial cells
(47). In another study, carvacrol did not influence the
motility of Bacillus cereus, but significantly inhibited
toxin production at doses below its MIC [48]. In the
present study, intestinal lesions were alleviated linearly
with increased EO dosages despite of unaffected C. per-
fringens populations. These results suggest that thymol
and carvacrol might influence C. perfringens adhesion to
intestinal mucosa or decrease toxin production without
affecting its numbers, which need further studies to be
verified. Furthermore, previous studies have shown that
supplemental EO can enhance cellular and humeral im-
munity in chickens, which might be involved in affecting
intestinal microbiota and gut health [49, 50].
Conclusions
The present study showed that thymol and carvacrol
possessed strong antibacterial activity against pathogenic
bacterial strains and weak activity towards beneficial
Lactobacillus strains in vitro. In addition, an additive ef-
fect was found when thymol and carvacrol were applied
in combination. In broiler chickens challenged with C.
perfringens, dietary supplementation of thymol and
carvacrol-bearing EO alleviated intestinal lesions, which
might be related to changes in intestinal microbiota.
More specific studies are required to improve luminal
availability of EO constituents, and clarify how EO affect
intestinal microbiota in vivo.
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